Business Standard

MEA to support govt panel to facilitate firms interested in Covid vaccine

The purpose of the group is to keep India in the forefront of any ongoing effort worldwide to innovate, prepare, produce and launch candidate vaccines to deal with the Covid-19 pandemic, for India and

covid, coronavirus, vaccine, drug, pharma
Premium

The regulator can then decide on the nature of trials that may be needed before a decision can be taken on the use of any candidate vaccine in India, he said.

Press Trust of India New Delhi
The Ministry of External Affairs on Thursday said with its inputs and support, the national expert group on vaccine administration for Covid-19 will help Indian firms interested in any candidate vaccines, and facilitate the process of ensuring that relevant testing data is made available to India's regulatory agencies.

Asked about the nature of collaboration India is considering with Russian vaccine maker RDIF and is India confident that all protocols have been followed by the firm, Ministry of External Affairs Spokesperson Anurag Srivastava said the government has set up an national expert group on vaccine administration for Covid-19.

The purpose of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in